-
,for, Item ID-
- #1033566
- Siemens #10333349
Immunoassay Reagent Advia Centaur® BR CA 27.29 For Advia Centaur CP / Centaur XP / Centaur XPT Immunoassay Systems 50 Tests
REAGENT, ADVIA CENTAUR BR 50TESTS D/S
No Image
Features
- The ADVIA Centaur CP BR assay is an in vitro diagnostic test for the quantitative serial determination of cancer antigen CA 27.29 in human serum using the ADVIA Centaur CP System
- The test is intended for use as an aid in monitoring patients previously treated for Stage II or Stage III breast cancer
- Serial testing for CA 27.29 in the serum of patients who are clinically free of disease should be used in conjunction with other clinical methods used for the early detection of cancer recurrence
- More …
Product Details Email
Product Specifications
| McKesson # | 1033566 |
|---|---|
| Manufacturer # | 10333349 |
| Brand | Advia Centaur® |
| Manufacturer | Siemens |
| Country of Origin | United States |
| Alternate Manufacturer Number | 116734 |
| Application | Immunoassay Reagent |
| Buy American Act (BAA) Compliant | Yes |
| For Use With | For Advia Centaur CP / Centaur XP / Centaur XPT Immunoassay Systems |
| Number of Tests | 50 Tests |
| Sample Type | Serum Sample |
| Specialty | Immunoassay |
| Test Category | Cancer Screening |
| Test Method | Direct Chemiluminescent Technology |
| Test Name | BR CA 27.29 |
| Test Type | Antigen Detection |
| Trade Agreement Act (TAA) Compliant | Yes |
| UNSPSC Code | 41116004 |
WARNING: This product can expose you to chemicals which are known to the State of California to cause cancer and birth defects or other reproductive harm. For more information, go to www.p65Warnings.ca.gov.
Features
- The ADVIA Centaur CP BR assay is an in vitro diagnostic test for the quantitative serial determination of cancer antigen CA 27.29 in human serum using the ADVIA Centaur CP System
- The test is intended for use as an aid in monitoring patients previously treated for Stage II or Stage III breast cancer
- Serial testing for CA 27.29 in the serum of patients who are clinically free of disease should be used in conjunction with other clinical methods used for the early detection of cancer recurrence
- WARNING: Cancer and Reproductive Harm - www.P65Warnings.ca.gov
More Information
Related Products
-
,for, Item ID-
- #1034108
- Siemens #10471899
Frequently Viewed Together
-
,for, Item ID-
- #848468
- Ortho Clinical Diagnostics #6844056
-
,for, Item ID-
- #1091128
- Beckman Coulter #B84493
-
,for, Item ID-
- #914289
- Siemens #10309546
-
,for, Item ID-
- #719666
- Ortho Clinical Diagnostics #8552630
-
,for, Item ID-
- #661210
- Beckman Coulter #33600
-
,for, Item ID-
- #898804
- Siemens #10310041
-
,for, Item ID-
- #1119834
- Abbott #07P5020
-
,for, Item ID-
- #898795
- Siemens #10310026
-
,for, Item ID-
- #1033494
- Siemens #10319550
-
,for, Item ID-
- #899299
- Siemens #10309060
-
,for, Item ID-
- #899298
- Siemens #10310032
-
,for, Item ID-
- #939127
- Siemens #10309943
-
,for, Item ID-
- #1033461
- Siemens #10313526
-
,for, Item ID-
- #1034185
- Siemens #10696880
-
,for, Item ID-
- #1033327
- Siemens #10309970